Cargando…
Inhibition of SARS-CoV replication by siRNA
Serious outbreaks of severe acute respiratory syndrome (SARS), caused by the newly discovered coronavirus SARS-CoV, occurred between late 2002 and early 2003 and there is an urgent need for effective antiviral agents. RNA interference in animals and post-transcriptional gene silencing plants is medi...
Autores principales: | Wu, Chang-Jer, Huang, Hui-Wen, Liu, Chiu-Yi, Hong, Cheng-Fong, Chan, Yi-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114151/ https://www.ncbi.nlm.nih.gov/pubmed/15652970 http://dx.doi.org/10.1016/j.antiviral.2004.09.005 |
Ejemplares similares
-
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
por: Li, T, et al.
Publicado: (2005) -
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes
por: Baldassi, Domizia, et al.
Publicado: (2022) -
Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2
por: Friedrich, Maik, et al.
Publicado: (2022) -
Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread
por: Ambike, Shubhankar, et al.
Publicado: (2021) -
Suppression of SARS‐CoV‐2 Replication with Stabilized and Click‐Chemistry Modified siRNAs
por: Traube, Franziska R., et al.
Publicado: (2022)